Randomized controlled trial of a clinical decision support system for painful polyneuropathy.
Despite guidelines, painful neuropathy is often inappropriately treated. We aimed to determine the effectiveness of a clinical decision support system on guideline-recommended medication utilization. We randomized neurology providers, stratified by subspecialty, to a Best Practice Alert (BPA) linked to a Smartset or a BPA alone when seeing neuropathy patients. The primary outcome was the proportion of patients with uncontrolled nerve pain prescribed a guideline-recommended medication. Generalized estimating equations were used to assess effectiveness. 75 neurology providers (intervention:38,control:37) treated 2,697 neuropathy patients (intervention:1026,control:671). Providers did not acknowledge the BPA in 1928 (71.5%) visits. Only 4 of 8 intervention arm neurologists that treated patients with uncontrolled nerve pain opened the Smartset. The intervention was not associated with guideline-recommended medication utilization (OR:0.52,0.18-1.48, intervention:52.0%,control:54.8%). Our intervention did not improve prescribing practices for painful neuropathy. Physicians typically ignored the BPAs/Smartset; therefore, future studies should mandate their use or employ alternate strategies. This article is protected by copyright. All rights reserved.